FDA plan highlights drug safety efforts

被引：0

|

作者：

不详

机构：

来源：

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY | 1999年 / 56卷 / 05期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：408 / 408

页数：1

相关论文

共 50 条

[41] FDA Sets Policies to Enhance Drug Security and Safety
Wechsler, Jill
BIOPHARM INTERNATIONAL, 2015, 28 (02) : 10 - 11
[42] Report on Drug Safety and the US FDA by the Institute of Medicine
Anthony W. Fox
International Journal of Pharmaceutical Medicine, 2006, 20 (5) : 289 - 291
[43] US FDA enhancing postmarketing drug safety surveillance
Reactions Weekly, 2019, 1780 (1) : 3 - 3
[44] Access and Safety-The FDA Drug Approval Conundrum
Good, Chester B.
Peasah, Samuel K.
JAMA NETWORK OPEN, 2024, 7 (07)
[45] US FDA 2009 drug safety warnings analysed
Reactions Weekly, 2012, 1388 (1) : 4 - 4
[46] FDA sets policies to enhance drug security and safety
Wechsler, Jill
Pharmaceutical Technology, 2015, 39 (02) : 16 - 19
[47] New FDA guidance on drug safety information communication
Reactions Weekly, 2007, 1142 (1) : 2 - 2
[48] FDA needs more sophisticated approach to drug safety
Christie, B
BRITISH MEDICAL JOURNAL, 2005, 330 (7501): : 1166 - 1166
[49] US FDA Enhancing Postmarketing Drug Safety Surveillance
不详
PHARMACEUTICAL MEDICINE, 2020, 34 (01) : 64 - 64
[50] A Difficult Balance - Pain Management, Drug Safety, and the FDA
Woodcock, Janet
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (22): : 2105 - 2107

← 1 2 3 4 5 →